Using DNA from mice, cows and a woodchuck virus, researchers at the University of Pennsylvania reprogrammed a disabled form of human HIV-1 to create "serial killer" T-cells that seek and destroy leukemia cells and then remain in the body to prevent recurrence of the cancer. The treatment successfully induced remission in one man with leukemia, and doctors hope to use this new tool to target many other forms of cancer.

Related Summaries